Accelerate Diagnostics Inc (AXDX)
0.882
-0.03
(-3.74%)
USD |
NASDAQ |
May 17, 16:00
0.8823
0.00 (0.00%)
After-Hours: 20:00
Accelerate Diagnostics Free Cash Flow: -36.82M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -36.82M |
December 31, 2023 | -41.23M |
September 30, 2023 | -43.02M |
June 30, 2023 | -47.58M |
March 31, 2023 | -49.61M |
December 31, 2022 | -49.28M |
September 30, 2022 | -51.97M |
June 30, 2022 | -51.02M |
March 31, 2022 | -47.60M |
December 31, 2021 | -47.93M |
September 30, 2021 | -45.92M |
June 30, 2021 | -46.68M |
March 31, 2021 | -47.10M |
December 31, 2020 | -51.76M |
September 30, 2020 | -55.46M |
June 30, 2020 | -59.52M |
March 31, 2020 | -63.62M |
December 31, 2019 | -65.12M |
September 30, 2019 | -65.56M |
June 30, 2019 | -66.27M |
March 31, 2019 | -70.93M |
December 31, 2018 | -68.75M |
September 30, 2018 | -68.43M |
June 30, 2018 | -65.10M |
March 31, 2018 | -60.38M |
Date | Value |
---|---|
December 31, 2017 | -58.71M |
September 30, 2017 | -57.46M |
June 30, 2017 | -55.38M |
March 31, 2017 | -56.63M |
December 31, 2016 | -55.82M |
September 30, 2016 | -53.86M |
June 30, 2016 | -50.44M |
March 31, 2016 | -45.51M |
December 31, 2015 | -38.78M |
September 30, 2015 | -33.20M |
June 30, 2015 | -30.70M |
March 31, 2015 | -24.78M |
December 31, 2014 | -20.72M |
September 30, 2014 | -18.17M |
June 30, 2014 | -14.37M |
March 31, 2014 | -12.06M |
December 31, 2013 | -10.91M |
September 30, 2013 | -9.259M |
June 30, 2013 | -6.665M |
March 31, 2013 | -4.841M |
October 31, 2012 | -1.966M |
July 31, 2012 | -0.912M |
April 30, 2012 | -0.2787M |
January 31, 2012 | -0.0317M |
October 31, 2011 | 0.3185M |
Free Cash Flow Range, Past 5 Years
-66.27M
Minimum
Jun 2019
-36.82M
Maximum
Mar 2024
-51.65M
Average
-49.44M
Median
Free Cash Flow Benchmarks
Achieve Life Sciences Inc | -21.46M |
ENDRA Life Sciences Inc | -9.220M |
Tivic Health Systems Inc | -7.751M |
Spectral AI Inc | -12.03M |
Perspective Therapeutics Inc | -23.28M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -8.452M |
Cash from Investing (Quarterly) | -0.513M |
Cash from Financing (Quarterly) | 11.44M |
Free Cash Flow Per Share (Quarterly) | -0.4665 |
Free Cash Flow to Equity (Quarterly) | -10.52M |
Free Cash Flow to Firm (Quarterly) | -6.715M |
Free Cash Flow Yield | -281.3% |